Literature DB >> 20160430

Curcumin inhibits the growth, induces apoptosis and modulates the function of pituitary folliculostellate cells.

Christian Schaaf1, Bing Shan, Chiara Onofri, Günter K Stalla, Eduardo Arzt, Tobias Schilling, Marcelo J Perone, Ulrich Renner.   

Abstract

The polyphenol curcumin (diferuloylmethane) is the active componenet of the spice plant Curcuma longa and has been shown to exert multiple actions on mammalian cells. We have studied its effect on folliculostellate (FS) TtT/GF mouse pituitary cells, representative of a multifunctional, endocrine inactive cell type of the anterior pituitary. Proliferation of TtT/GF cells was inhibited by curcumin in a monolayer cell culture and in the colony formation assay in soft agar. Fluorescence-activated cell-sorting (FACS) analysis demonstrated curcumin-induced cell cycle arrest at G(2)/M accompanied by inhibition of cyclin D(1) protein expression. Curcumin had a small effect on necrosis of TtT/GF cells, but it mainly stimulated apoptosis as demonstrated by FACS analysis (Annexin V-fluorescein isothiocyannate/7-aminoactinomycin D staining). Curcumin-induced apoptosis involved suppression of Bcl-2, stimulation of cleaved caspase-3 and induction of DNA fragmentation. Functional studies on FS cell-derived compounds showed that curcumin inhibited mRNA synthesis and release of angiogenic vascular endothelial growth factor-A (VEGF-A). Immune-like functions of FS cells were impaired since curcumin downregulated Toll-like receptor 4, reduced nuclear factor-kappaB expression and suppressed bacterial endotoxin-induced interleukin-6 (IL-6) secretion. The inhibitory action of curcumin on VEGF-A and IL-6 production was also found in primary rat pituitary cell cultures, in which FS cells are the only source of these proteins. The observed effects of curcumin on FS cell growth, apoptosis and functions may have therapeutic consequences for the intrapituitary regulation of hormone production and release as well as for pituitary tumor pathogenesis. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20160430     DOI: 10.1159/000287236

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  6 in total

Review 1.  Neuroprotection by spice-derived nutraceuticals: you are what you eat!

Authors:  Ramaswamy Kannappan; Subash Chandra Gupta; Ji Hye Kim; Simone Reuter; Bharat Bhushan Aggarwal
Journal:  Mol Neurobiol       Date:  2011-03-01       Impact factor: 5.590

2.  Curcumin acts anti-proliferative and pro-apoptotic in human meningiomas.

Authors:  S Curic; Y Wu; B Shan; C Schaaf; D Utpadel; M Lange; D Kuhlen; M J Perone; E Arzt; G K Stalla; U Renner
Journal:  J Neurooncol       Date:  2013-05-11       Impact factor: 4.130

3.  Curcuminoid binding to embryonal carcinoma cells: reductive metabolism, induction of apoptosis, senescence, and inhibition of cell proliferation.

Authors:  Wolfgang W Quitschke
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

Review 4.  Molecular Network Basis of Invasive Pituitary Adenoma: A Review.

Authors:  Qi Yang; Xuejun Li
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-24       Impact factor: 5.555

5.  Lycopene and beta-carotene induce growth inhibition and proapoptotic effects on ACTH-secreting pituitary adenoma cells.

Authors:  Natália F Haddad; Anderson J Teodoro; Felipe Leite de Oliveira; Nathália Soares; Rômulo Medina de Mattos; Fábio Hecht; Rômulo Sperduto Dezonne; Leandro Vairo; Regina Coeli Dos Santos Goldenberg; Flávia Carvalho Alcântara Gomes; Denise Pires de Carvalho; Mônica R Gadelha; Luiz Eurico Nasciutti; Leandro Miranda-Alves
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

6.  Curcuma DMSO extracts and curcumin exhibit an anti-inflammatory and anti-catabolic effect on human intervertebral disc cells, possibly by influencing TLR2 expression and JNK activity.

Authors:  Marina Klawitter; Lilian Quero; Juergen Klasen; Alexia N Gloess; Babette Klopprogge; Oliver Hausmann; Norbert Boos; Karin Wuertz
Journal:  J Inflamm (Lond)       Date:  2012-08-21       Impact factor: 4.981

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.